NeuroPace (NPCE) Preferred Shares (2020)

NeuroPace (NPCE) posted quarterly Preferred Shares of $58.18 for Q3 2020, down 50.0% quarter-over-quarter from $116.35 in Q2 2020.

NeuroPace (NPCE) Preferred Shares (2020) Analysis & Trends

NeuroPace's Preferred Shares history runs 1 years deep, the most recent figure standing at $58.18 for Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn	-
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn	-
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	-
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	-
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn	-
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	-
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn	-
10	NeuroPace	463.14 Mn	411.44 Mn	18.91 Mn	-

Download Data

Date	Value
Sep 30, 2020	58.18
Jun 30, 2020	116.35